Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Cardinal HealthLTS:0HTG +1.16%81 Earnings Yield (Joel Greenblatt) % is 4.28% as of Mar. 2026, which is 4% below its 10-year median of 4.48. GuruFocus rates LTS:0HTG with a GF Score™ of 81/100 and a GF Value™ of $141.64 (Significantly Overvalued). The stock has 6 warning signs investors should review. Among 121 Medical Distribution companies, Cardinal Health ranks worse than 66.94% on this metric.
Cardinal Health's Enterprise Value for the quarter that ended in Mar. 2026 was $54,497 Mil.
Cardinal Health's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 was $2,347 Mil. Cardinal Health's Earnings Yield (Joel Greenblatt) for the quarter that ended in Mar. 2026 was 4.28%.
The historical rank and industry rank for Cardinal Health's Earnings Yield (Joel Greenblatt) % or its related term are showing as below:
LTS:0HTG'
s Earnings Yield (Joel Greenblatt) % Range Over the Past 10 Years
Min: -22.01 Med: 4.48 Max: 11.21
Current: 3.98
During the past 13 years, the highest Earnings Yield (Joel Greenblatt) of Cardinal Health was 11.21%. The lowest was -22.01%. And the median was 4.48%.
LTS:0HTG's Earnings Yield (Joel Greenblatt) % is ranked worse than 66.94% of 121
companies
in the Medical Distribution industry
Industry Median: 6.26
vs LTS:0HTG: 3.98
Joel Greenblatt's definition of earnings yield has the same problems the regular earnings yield does. It does not consider the growth of the company. It only looks at one-year's business operation. For cyclical companies, the earnings yield is usually highest at the peak of the business cycle. But these earnings are rarely sustainable.
A better indicator of the attractiveness of an investment which takes growth into account is the Forward Rate of Return (Yacktman) %. Cardinal Health's Forward Rate of Return (Yacktman) % for the quarter that ended in Mar. 2026 was 0.00%. The Forward Rate of Return uses the normalized Free Cash Flow of the past five years, and considers growth. The forward rate of return can be thought of as the return that investors buying the stock today can expect from it in the future.
Cardinal Health (LTS:0HTG) Earnings Yield (Joel Greenblatt) % Explanation
Joel Greenblatt defines the earnings yield using the above equation because it more accurately reflects the company's profitability relative to its stock price. Items like interest payment and tax etc. are not directly related to the company's operational profitability.
Enterprise Value instead of market cap (share price) is used in the calculation because it is the real price stock and bond investors together pay for the company.
Be Aware
Joel Greenblatt's definition of earnings yield has the same problems the regular earnings yield does. It does not consider the growth of the company. It only looks at one-year's business operation. For cyclical companies, the earnings yield is usually highest at the peak of the business cycle. But these earnings are rarely sustainable.
Cardinal Health Earnings Yield (Joel Greenblatt) % Related Terms
Cardinal Health Earnings Yield (Joel Greenblatt) % Historical Data
* Premium members only.
The historical data trend for Cardinal Health's Earnings Yield (Joel Greenblatt) % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cardinal Health Earnings Yield (Joel Greenblatt) % Chart
For the Medical Distribution subindustry, Cardinal Health's Earnings Yield (Joel Greenblatt) %, along with its competitors' market caps and Earnings Yield (Joel Greenblatt) % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Cardinal Health Earnings Yield (Joel Greenblatt) % vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Cardinal Health's Earnings Yield (Joel Greenblatt) % distribution charts can be found below:
* The bar in red indicates where Cardinal Health's Earnings Yield (Joel Greenblatt) % falls into.
Cardinal Health Earnings Yield (Joel Greenblatt) % Calculation
In his book, The Little That Beat the Market, hedge fund manager Joel Greenblatt defines Earnings Yield as operating income divided by enterprise value.
Cardinal Healths Earnings Yield (Joel Greenblatt) for the fiscal year that ended in Jun. 2025 is calculated as
Cardinal Health's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $2,347 Mil.
What does a Earnings Yield (Joel Greenblatt) % of 4.28% mean?
Cardinal Health (LTS:0HTG) has a Earnings Yield (Joel Greenblatt) % of 4.28% as of Mar. 2026. Joel Greenblatt's earnings yield equals the ratio of earnings before interest and taxes to enterprise value. View historical data on Cardinal Health and its competitors. This is near median its historical median of 4.48. According to the industry distribution chart, Cardinal Health ranks #81 out of 121 companies in the Medical Distribution industry, placing it in the top 66.9%.
Is Cardinal Health's Earnings Yield (Joel Greenblatt) % too high?
Cardinal Health's current Earnings Yield (Joel Greenblatt) % of 4.28% is near median its 10-year median of 4.48. The Medical Distribution industry median Earnings Yield (Joel Greenblatt) % is 6.26. Cardinal Health's value of 4.28% is 31.6% below this industry median. Based on the distribution chart, Cardinal Health ranks #81 out of 121 companies in the Medical Distribution industry, which is below the industry midpoint. Overall, Cardinal Health has a GF Score™ of 81/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Cardinal Health's Earnings Yield (Joel Greenblatt) % compare to COR and HSIC?
According to the Medical Distribution industry distribution chart, Cardinal Health ranks #81 out of 121 companies for Earnings Yield (Joel Greenblatt) %. This places Cardinal Health in the lower half of its industry. The industry median Earnings Yield (Joel Greenblatt) % is 6.26. Cardinal Health's value of 4.28% is 31.6% below this benchmark. While the company's 10-year median is 4.48 vs. the industry median of 6.26, Cardinal Health has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Earnings Yield (Joel Greenblatt) % for a Medical Distribution company?
The median Earnings Yield (Joel Greenblatt) % among Medical Distribution companies is 6.26, based on 121 companies in the industry. Companies in the top quartile (top 25%) have a Earnings Yield (Joel Greenblatt) % significantly above this median, while those in the bottom quartile fall well below. However, Earnings Yield (Joel Greenblatt) % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Cardinal Health's current Earnings Yield (Joel Greenblatt) % of 4.28% is 31.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Earnings Yield (Joel Greenblatt) % mean?
A high Earnings Yield (Joel Greenblatt) % can signal that a stock is expensive relative to its fundamentals. Joel Greenblatt's earnings yield equals the ratio of earnings before interest and taxes to enterprise value. View historical data on Cardinal Health and its competitors. For the Medical Distribution industry, the median Earnings Yield (Joel Greenblatt) % is 6.26 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Cardinal Health's current Earnings Yield (Joel Greenblatt) % is 4.28%, which is near median its own 10-year median of 4.48. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cardinal Health stock overvalued right now?
Based on GuruFocus' analysis, Cardinal Health (LTS:0HTG) is currently considered Significantly Overvalued. The stock's GF Value™ is $141.64, compared to a current price of $232.90 — trading 64.4% above its estimated fair value. The current Earnings Yield (Joel Greenblatt) % is 4.28%, which is near median its 10-year median of 4.48 and 31.6% below the Medical Distribution industry median of 6.26. Cardinal Health's overall GF Score™ is 81/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Earnings Yield (Joel Greenblatt) % calculated?
Earnings Yield (Joel Greenblatt) % is calculated from a company's financial statements. For Cardinal Health (LTS:0HTG), the current Earnings Yield (Joel Greenblatt) % is 4.28% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Cardinal Health (LTS:0HTG) Overvalued in 2026?
Based on GuruFocus' analysis, Cardinal Health stock appears to be overvalued.
The current stock price of $232.90 is trading 64.4% above its estimated GF Value™ of $141.64.
GuruFocus considers Cardinal Health to be Significantly Overvalued.
Key valuation signals for LTS:0HTG:
Earnings Yield (Joel Greenblatt) %: 4.28% (near median its 10-year median of 4.48)
GF Value™: $141.64 vs. price of $232.90 (64.4% above fair value)
Industry Position: 31.6% below the Medical Distribution median (#81 of 121)
No single metric tells the full story. See the LTS:0HTG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Cardinal Health is one of three leading pharmaceutical wholesalers in the US, engaged in sourcing and distributing of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. Cardinal, Cencora, and McKesson hold well over 90% of the US pharmaceutical wholesale industry. Cardinal Health also supplies medical-surgical products and equipment to healthcare facilities in North America, Europe, and Asia.
81GF Score
Get the complete analysis for LTS:0HTG
Earnings Yield (Joel Greenblatt) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LTS:0HTG has been successfully added to your 
